Refreshing results…
FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease
Download from www.nature.comCancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
Download from api.wiley.comMissing publications? Search for publications with a matching author name.